RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY pelareorep + CD3 bispecific antibody true-killer comboNotable I watch BNN, CNBC and Fox Business and listened to a number of biotech analysts promoting companies they feel have the potential and yet not one have mentioned ONC. This includes RBC so they may be watching but they're not promoting with any enthusiasm. Plus the sp estimates have never come close and lack of promotion is one reason.